Yüklüyor......
Effects of hexanic extract of serenoa repens (permixon(®) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
BACKGROUND: Chronic prostatic inflammation (CPI) could be a cause of symptomatic or complicated benign prostatic hyperplasia (BPH). In previous in vitro and in vivo studies, Hexanic Extract of Serenoa repens (HESr) namely Permixon(®) has demonstrated potent anti‐inflammatory properties. With the aim...
Kaydedildi:
| Yayımlandı: | Prostate |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5049653/ https://ncbi.nlm.nih.gov/pubmed/26306400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23059 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|